The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic
Open accessAbstract
The most up-to-date estimates demonstrate very heterogeneous spread of HIV-1, and more than 30 million people are now living with HIV-1 infection, most of them in sub-Saharan Africa. The efficiency of transmission of HIV-1 depends primarily on the concentration of the virus in the infectious host. Although treatment with antiviral agents has proven a very effective way to improve the health and survival of infected individuals, as we discuss here, the epidemic will continue to grow unless greatly improved prevention strategies can be developed and implemented. No prophylactic vaccine is on the horizon. However, several behavioral and structural strategies have made a difference--male circumcision provides substantial protection from sexually transmitted diseases, including HIV-1, and the application of antiretroviral agents for prevention holds great promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Gralton, B. (2008) · Art monthly Australia · Cited by 3,001
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020298 · Cited by 2,451
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., Williams, C. F., Campbell, R. T., & Ndinya-Achola, J. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60312-2 · Cited by 2,292 · cited 1×
“Three recent randomized, controlled clinical trials have demonstrated the efficacy of adult male circumcision in reducing female-to-male transmission of HIV-1 by approximately 50%–60% (110–112) .”
Fleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chaudhary, M. A., Chen, M. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60313-4 · Cited by 2,226
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,832
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449 · cited 1×
“Most recently, Brass et al. (28) applied a unique approach, using siRNA to identify “HIV dependency factors.””
Pneumocystis Pneumonia—Los Angeles
(1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540130018007 · Cited by 1,447
Grosskurth, H., Todd, J., Mwijarubi, E., Mayaud, P., Nicoll, A., ka-Gina, G., Newell, J., Grosskurth, H., Todd, J., Mayaud, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91380-7 · Cited by 1,406
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
HIV preferentially infects HIV-specific CD4+ T cells
Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P., Kuruppu, J., Kunstman, K., Wolinsky, S., et al. (2002) · Nature · doi:10.1038/417095a · Cited by 1,262
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. (2007) · Science · doi:10.1126/science.1143767 · Cited by 1,235
AIDS as a Zoonosis: Scientific and Public Health Implications
Hahn, B. H., Shaw, G. M., De, K. M., Cock, & Sharp, P. M. (2000) · Science · doi:10.1126/science.287.5453.607 · Cited by 1,235
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Newell, M.-L., Coovadia, H., Cortina-Borja, M., Rollins, N., Gaillard, P., & Dabis, F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17140-7 · Cited by 1,182
Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., et al. (1995) · Science · doi:10.1126/science.270.5238.988 · Cited by 1,155
Mehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P., & Markowitz, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041196 · Cited by 1,146
The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility
Gonzalez, E., Kulkarni, H., Bolivar, H., Mangano, A., Sanchez, R., Catano, G., Nibbs, R. J., Freedman, B. I., Quinones, M. P., Bamshad, M. J., et al. (2005) · Science · doi:10.1126/science.1101160 · Cited by 1,129
Royce, R. A., Seña, A., Cates, W., & Cohen, M. S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361507 · Cited by 1,065
Self-citationCooper, E. R., Charurat, M., Mofenson, L., Hanson, I. C., Pitt, J., Diaz, C., Hayani, K., Handelsman, E., Smeriglio, V., Hoff, R., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204150-00009 · Cited by 1,058
Cao, Y., Qin, L., Zhang, L., Safrit, J., & Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320401 · Cited by 1,037
Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986
Robertson, D. L., Anderson, J. P., Bradac, J. A., Carr, J. K., Foley, B., Funkhouser, R. K., Gao, F., Hahn, B. H., Kalish, M. L., Kuiken, C., et al. (2000) · Science · doi:10.1126/science.288.5463.55d · Cited by 964
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Pneumocystis pneumonia--Los Angeles.
(1981) · PubMed · Cited by 916
Van Damme, L., Ramjee, G., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., Sirivongrangson, P., Tshibaka, L. M., Ettiègne-Traoré, V., Uaheowitchai, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11079-8 · Cited by 797
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial
Wawer, M. J., Sewankambo, N. K., Serwadda, D., Quinn, T. C., Kiwanuka, N., Li, C., Lutalo, T., Nalugoda, F., Gaydos, C. A., Moulton, L. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06439-3 · Cited by 787
The role of sexually transmitted diseases in HIV transmission
Galvin, S. R., & Cohen, M. S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro794 · Cited by 784
Self-citationHIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection
Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O. J., Demarest, J. F., Montefiori, D., Orenstein, J. M., Fox, C., Schrager, L. K., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320402 · Cited by 730
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
Pilcher, C. D., Tien, H. C., Eron, Jr., Vernazza, P. L., Leu, S., Stewart, P. W., Goh, L., Cohen, M. S., & Quest Study and the Duke‐UNC‐Emory Acute HIV Consortium (2004) · The Journal of Infectious Diseases · doi:10.1086/386333 · Cited by 662
Self-citationImmune restoration disease after antiretroviral therapy
French, M. A., Price, P., & Stone, S. F. (2004) · AIDS · doi:10.1097/01.aids.0000131375.21070.06 · Cited by 651
Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV
Taha, T. E., Hoover, D. R., Dallabetta, G. A., Kumwenda, N. I., Mtimavalye, L. A. R., Yang, L.-P., Liomba, G. N., Broadhead, R. L., Chiphangwi, J. D., & Miotti, P. G. (1998) · AIDS · doi:10.1097/00002030-199813000-00019 · Cited by 634
Jones, B. E., Young, S. M. M., Antoniskis, D., Davidson, P. T., Kramer, F., & Barnes, P. F. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1292 · Cited by 586
The dynamics of CD4+ T-cell depletion in HIV disease
McCune, J. M. (2001) · Nature · doi:10.1038/35073648 · Cited by 583
Stramer, S. L., Glynn, S. A., Kleinman, S. H., Strong, D. M., Caglioti, S., Wright, D. J., Dodd, R. Y., & Busch, M. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040085 · Cited by 536
Curran, J. W., Debas, H. T., Arya, M., Kelley, P., Knobler, S., & Pray, L. A. (2005) · Cited by 534
Population-Level HIV Declines and Behavioral Risk Avoidance in Uganda
Stoneburner, R. L., & Low-Beer, D. (2004) · Science · doi:10.1126/science.1093166 · Cited by 517
Community-based approaches to HIV treatment in resource-poor settings
Farmer, P., Léandre, F., Mukherjee, J. S., Claude, M. S., Nevil, P., Smith-Fawzi, M. C., Koenig, S. P., Castro, A., Becerra, M. C., Sachs, J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05550-7 · Cited by 516
Moore, J. P., Kitchen, S. G., Pugach, P., & Zack, J. A. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322749567 · Cited by 494
Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa
Abu-Raddad, L. J., Patnaik, P., & Kublin, J. G. (2006) · Science · doi:10.1126/science.1132338 · Cited by 484
Bunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., Coutinho, A., Liechty, C., Madraa, E., Rutherford, G., et al. (2006) · AIDS · doi:10.1097/01.aids.0000196566.40702.28 · Cited by 463
Ferradini, L., Jeannin, A., Pinoges, L., Izopet, J., Odhiambo, D., Mankhambo, L., Karungi, G., Szumilin, E., Balandine, S., Fedida, G., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68580-2 · Cited by 450
Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis
Fraser, C., Hollingsworth, T. D., Chapman, R., de Wolf, F., & Hanage, W. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708559104 · Cited by 438
Corbett, E. L., Marston, B., Churchyard, G. J., & De Cock, K. M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68383-9 · Cited by 438
Self-citationRowland-Jones, S. L., Dong, T., Fowke, K. R., Kimani, J., Krausa, P., Newell, H., Blanchard, T., Ariyoshi, K., Oyugi, J., Ngugi, E., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4314 · Cited by 421
Conference on Retroviruses and Opportunistic Infections 2015
(2015) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30481-7 · Cited by 421
Tracing the origin and history of the HIV-2 epidemic
Lemey, P., Pybus, O. G., Wang, B., Saksena, N. K., Salemi, M., & Vandamme, A.-M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0936469100 · Cited by 413
Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients
Soumelis, V., Scott, I., Gheyas, F., Bouhour, D., Cozon, G., Cotte, L., Huang, L., Levy, J. A., & Liu, Y.-J. (2001) · Blood · doi:10.1182/blood.v98.4.906 · Cited by 398
Self-citationPreserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys
Letvin, N. L., Mascola, J. R., Sun, Y., Gorgone, D. A., Buzby, A. P., Xu, L., Yang, Z.-Y., Chakrabarti, B., Rao, S. S., Schmitz, J. E., et al. (2006) · Science · doi:10.1126/science.1124226 · Cited by 372
Roddy, R. E., Zekeng, L., Ryan, K. A., Tamoufé, U., Weir, S. S., & Wong, E. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390803 · Cited by 366
Fideli, Ü. S., Allen, S. A., Musonda, R., Trask, S., Hahn, B. H., Weiss, H., Mulenga, J., Kasolo, F., Vermund, S. H., & Aldrovandi, G. M. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201750290023 · Cited by 358
García-Lerma, J. G., Otten, R. A., Qari, S. H., Jackson, E., Cong, M.-E., Masciotra, S., Luo, W., Kim, C., Adams, D. R., Monsour, M., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050028 · Cited by 350
Padian, N. S., van der Straten, A., Ramjee, G., Chipato, T., de Bruyn, G., Blanchard, K., Shiboski, S., Montgomery, E. T., Fancher, H., Cheng, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60950-7 · Cited by 337
HIV and the Pathogenesis of AIDS
(1995) · Nature Medicine · doi:10.1038/nm0395-273 · Cited by 335
Kamali, A., Quigley, M., Nakiyingi, J., Kinsman, J., Kengeya-Kayondo, J., Gopal, R., Ojwiya, A., Hughes, P., Carpenter, L., & Whitworth, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12598-6 · Cited by 318
Pilcher, C. D., Joaki, G., Hoffman, I. F., Martinson, F. E., Mapanje, C., Stewart, P. W., Powers, K. A., Galvin, S., Chilongozi, D., Gama, S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3281532c82 · Cited by 290
Self-citationChakraborty, H., Sen, P. K., Helms, R. W., Vernazza, P. L., Fiscus, S. A., Eron, J. J., Patterson, B. K., Coombs, R. W., Krieger, J. N., & Cohen, M. S. (2001) · AIDS · doi:10.1097/00002030-200103300-00012 · Cited by 287
Self-citationBucher, H. C., Griffith, L. E., Guyatt, G. H., Sudre, P., Naef, M., Sendi, P., & Battegay, M. (1999) · Aids · doi:10.1097/00002030-199903110-00009 · Cited by 282
Ito, T., Kanzler, H., Duramad, O., Cao, W., & Liu, Y.-J. (2006) · Blood · doi:10.1182/blood-2005-07-2709 · Cited by 281
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.
Feldblum, P. J., Adeiga, A., Bakare, R., Wevill, S., Lendvay, A., Obadaki, F., Olayemi, M. O., Wang, L., Nanda, K., & Rountree, W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001474 · Cited by 280
Kägi, D., Seiler, P., Pavlovic, J., Ledermann, B., Bürki, K., Zinkernagel, R. M., & Hengartner, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251209 · Cited by 278
Peterson, L., Taylor, D., Roddy, R., Belai, G., Phillips, P., Nanda, K., Grant, R., Clarke, E. E. K., Doh, A. S., Ridzon, R., et al. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020027 · Cited by 277
Understanding the genetic diversity of HIV-1.
McCutchan, F. E. (2000) · PubMed · Cited by 270
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
Kaul, R., Trabattoni, D., Bwayo, J. J., Arienti, D., Zagliani, A., Mwangi, F. M., Kariuki, C., Ngugi, E. N., MacDonald, K. S., Ball, T. B., et al. (1999) · AIDS · doi:10.1097/00002030-199901140-00004 · Cited by 267
An HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257 · cited 2×
“However, attempts to develop a protective vaccine have been severely compro - mised by an incomplete understanding of protective HIV-1 immunity and the inability to induce a sufficiently potent immune response against HIV-1 (122, 123).”
T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS
Zinkernagel, R. M., & Hengartner, H. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90005-1 · Cited by 232
Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1
Cohen, M. S., Gay, C., Kashuba, A. D. M., Blower, S., & Paxton, L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00010 · Cited by 231
Self-citationThe interaction of HIV with dendritic cells: outcomes and pathways
Piguet, V., & Steinman, R. M. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.010 · Cited by 218
Jackson, J. B., Becker-Pergola, G., Guay, L. A., Musoke, P., Mracna, M., Fowler, M. G., Mofenson, L. M., Mirochnick, M., Mmiro, F., & Eshleman, S. H. (2000) · AIDS · doi:10.1097/00002030-200007280-00001 · Cited by 208
Simian Immunodeficiency Virus Infection of Chimpanzees
Sharp, P. M., Shaw, G. M., & Hahn, B. H. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.3891-3902.2005 · Cited by 203
HIV and the Pathogenesis of AIDS
Levy, J. A. (2007) · ASM Press eBooks · doi:10.1128/9781555815653 · Cited by 198
Self-citationPing, L.-H., Nelson, J. A. E., Hoffman, I. F., Schock, J., Lamers, S. L., Goodman, M., Vernazza, P., Kazembe, P., Maida, M., Zimba, D., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6271-6281.1999 · Cited by 196
Self-citationHIV infection among intravenous drug users: epidemiology and risk reduction.
Jarlais, D., & Friedman, S. R. (1987) · PubMed · Cited by 194
Damond, F., Worobey, M., Campa, P., Farfara, I., Colin, G., Matheron, S., Brun-Vézinet, F., Robertson, D. L., & Simon, F. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/0889222041217392 · Cited by 186
(2006) · PubMed · Cited by 182
Forthal, D. N., Gilbert, P. B., Landucci, G., & Phan, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6596 · Cited by 179
Limited Durability of Viral Control following Treated Acute HIV Infection
Kaufmann, D. E., Lichterfeld, M., Altfeld, M., Addo, M. M., Johnston, M. N., Lee, P. K., Wagner, B. S., Kalife, E. T., Strick, D., Rosenberg, E. S., et al. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010036 · Cited by 179
Underhill, K., Montgomery, P., & Operario, D. (2007) · BMJ · doi:10.1136/bmj.39245.446586.be · Cited by 176
Whalen, C. C., Nsubuga, P., Okwera, A., Johnson, J. L., Hom, D. L., Michael, N. L., Mugerwa, R. D., & Ellner, J. J. (2000) · AIDS · doi:10.1097/00002030-200006160-00020 · Cited by 176
Integrating HIV Prevention and Treatment: From Slogans to Impact
Salomon, J. A., Hogan, D. R., Stover, J., Stanecki, K. A., Walker, N., Ghys, P. D., & Schwartländer, B. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020016 · Cited by 169
Drug Interactions Between Antiretroviral Drugs and Comedicated Agents
de Maat, M. M. R., Ekhart, G. C., Huitema, A. D. R., Koks, C. H. W., Mulder, J. W., & Beijnen, J. H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342030-00002 · Cited by 167
Korenromp, E. L., White, R. G., Orroth, K. K., Bakker, R., Kamali, A., Serwadda, D., Gray, R. H., Grosskurth, H., Habbema, J. D. F., & Hayes, R. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/425274 · Cited by 161
Acute HIV revisited: new opportunities for treatment and prevention
Pilcher, C. D., Eron, J. J., Galvin, S., Gay, C., & Cohen, M. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21540 · Cited by 159
Self-citationHomsy, J., Meyer, M., & Levy, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1437-1440.1990 · Cited by 155
Self-citationThe Global Impact of Scaling Up HIV/AIDS Prevention Programs in Low- and Middle-Income Countries
Stover, J., Bertozzi, S., Gutiérrez, J. P., Walker, N., Stanecki, K. A., Greener, R., Gouws, E., Hankins, C. A., Garnett, G. P., Salomon, J. A., et al. (2006) · Science · doi:10.1126/science.1121176 · Cited by 144
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review.
Jaffar, S. S., Grant, A. D., Whitworth, J. A. G., Smith, P. G., & Whittle, H. C. (2004) · Europe PMC (PubMed Central) · Cited by 141
Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection
Piantadosi, A. L., Chohan, B. H., Chohan, V., McClelland, R. S., & Overbaugh, J. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030177 · Cited by 140
Schmidt, B., Ashlock, B. M., Foster, H., Fujimura, S. H., & Levy, J. A. (2005) · Virology · doi:10.1016/j.virol.2005.09.059 · Cited by 140
Self-citationThe Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong?
Singh, J. A., & Mills, E. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020234 · Cited by 133
Donoval, B. A., LANDAY, A. L., Moses, S., Agot, K. E., Ndinya-Achola, J. O., Nyagaya, E., MacLean, I., & Bailey, R. C. (2006) · American Journal of Clinical Pathology · doi:10.1309/jvhqvdjdykm58eph · Cited by 124
Infection by Human Immunodeficiency Virus — CD4 is Not Enough
Levy, J. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611143352011 · Cited by 118
Self-citationDid Merck's Failed HIV Vaccine Cause Harm?
Cohen, J. (2007) · Science · doi:10.1126/science.318.5853.1048 · Cited by 98
Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions
Montefiori, D. C., Sattentau, Q. J., Flores, J., Esparza, J., Mascola, J. R., & on behalf of a Working Group convened by the Global HIV Vaccine Enterprise (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040348 · Cited by 87
Celum, C., Robinson, N. J., & Cohen, M. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/425272 · Cited by 81
Self-citationPromote HIV Chemoprophylaxis Research, Don't Prevent It
Grant, R. M., Buchbinder, S., Cates, W., Clarke, E. E. K., Coates, T. J., Cohen, M. S., Delaney, M., Flores, G., Goicochea, P., Gonsalves, G., et al. (2005) · Science · doi:10.1126/science.1116204 · Cited by 76
Self-citationvan der Valk, M., Casula, M., Weverling, G. J., van Kuijk, K., van Eck‐Smit, B. L. F., Hulsebosch, H.-J., Nieuwkerk, P. T., van Eeden, A., Brinkman, K., Lange, J. M. A., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900317 · Cited by 72
Self-citationThe Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan
Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020025 · Cited by 72
Wegbreit, J., Bertozzi, S., DeMaria, L., & PADIAN, N. S. (2006) · AIDS · doi:10.1097/01.aids.0000232229.96134.56 · Cited by 62
Latency and viral persistence in HIV-1 infection
Siliciano, J. D., & Siliciano, R. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11246 · Cited by 54
Preventing Sexual Transmission of HIV
Cohen, M. S. (2007) · Clinical Infectious Diseases · doi:10.1086/522552 · Cited by 45
Self-citationMechanisms of HIV-1 drug resistance
Larder, B. A. (2001) · AIDS · doi:10.1097/00002030-200100005-00005 · Cited by 44
Lieberman, J. (2004) · AIDS · doi:10.1097/01.aids.0000131320.75396.4d · Cited by 28
Antiretroviral Therapy for Prevention of HIV Infection: New Clues From an Animal Model
Cohen, M. S., & Kashuba, A. D. M. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050030 · Cited by 23
Self-citation
Cited by
Lester, R. T., Ritvo, P., Mills, E. J., Kariri, A., Karanja, S., Chung, M. H., Jack, W., Habyarimana, J., Sadatsafavi, M., Najafzadeh, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61997-6 · Cited by 1,278
Selenium, Selenoproteins, and Immunity
Avery, J., & Hoffmann, P. (2018) · Nutrients · doi:10.3390/nu10091203 · Cited by 894
Genome-Scale RNAi Screen for Host Factors Required for HIV Replication
Zhou, H., Xu, M., Huang, Q., Gates, A. T., Zhang, X. D., Castle, J. C., Stec, E., Ferrer, M., Strulovici, B., Hazuda, D. J., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.004 · Cited by 789
Brief History of Pandemics (Pandemics Throughout History)
Huremović, D. (2019) · Psychiatry of Pandemics · doi:10.1007/978-3-030-15346-5_2 · Cited by 357
Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward
Padian, N. S., Buvé, A., Balkus, J., Serwadda, D., & Cates, W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60885-5 · Cited by 264
Metadata
- Authors
- Cohen, M. S., Hellmann, N., Levy, J. A., DeCock, K., & Lange, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-04-01
- Volume
- 118
- Issue
- 4
- Pages
- 1244-1254
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2164640003
- Cited by
- 304
- References
- 120
- FWCI
- 19.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.